Buy Aurinia Pharmaceuticals Stock | AUPH Stock Price & Latest News | Public
AUPH

Aurinia Pharmaceuticals

$0.00 (0.00%)Today

    About AUPH

    Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.1
    -0.19
    -0.29
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.18

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,96B
    Volume21,43k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$21.93
    1 Year Low$4.57
    Open$15.68
    High$15.74
    Low$15.09

    Buy any stock with any amount of money.

    Download the App
    Download the app